Symbolbild · KI-generiert
BioSyent Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Listed on the TSX Venture Exchange under the trading symbol 'RX', BioSyent is a profitable growth-oriented specialty healthcare products company focused on acquiring or in-licensing, marketing and distributing innovative pharmaceutical and oral health products that have been successfully developed, are safe and effective, and have a proven track record of improving the lives of patients. BioSyent supports the healthcare professionals that treat these patients by marketing its products through its Pharmaceutical and Oral Health businesses, both in Canada and internationally.
Company description as published by the issuer via TMX Money.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| BioSyent Inc. | RX | TSXV | 121 Mio. USD |
| DIRTT Environmental Solutions Ltd. | DRT | TSX | 120 Mio. USD |
| Custom Health Holdings Inc. | CHLT | TSX | 122 Mio. USD |
| Medexus Pharmaceuticals Inc. | MDP | TSX | 115 Mio. USD |
| Cannara Biotech Inc. | LOVE | TSX | 131 Mio. USD |
| Organigram Global Inc. | OGI | TSX | 132 Mio. USD |
| Exagen Inc. | XGN | NASDAQ | 109 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.